MustGrow Announces Investor Initiatives, Presentation Today at The Future of Food Investment Conference
SASKATOON, Saskatchewan, Canada, Nov. 24, 2020 – MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (the “Company“, “MustGrow“) is pleased to announce its upcoming investor awareness initiatives. MustGrow continues to actively engage its key stakeholders – potential industry partners, shareholders, and prospective investors – by increasing awareness of its remarkable, natural, mustard-derived crop protection products.
TODAY: The Future of Food Investment Conference – SnowCap Ventures
Tuesday, Nov. 24th at 1:50 pm ET
One-On-One Investor Meetings – Hosted by CEO & COO of MustGrow Biologics
Monday-Tuesday, Nov. 30th-Dec. 1st
Please email firstname.lastname@example.org to schedule your one-on-one meeting with MustGrow.
AGRI Tech Venture Forum – Online Virtual Conference
Wednesday-Thursday Dec. 2nd-3rd
MustGrow’s Key Programs and Catalysts:
Bananas / Fusarium wilt TR4:
MustGrow has commenced testing of its biopesticide in Colombia to tackle the disease Fusarium wilt TR4, a devastating disease pathogen ravaging the $25 billion global banana industry. Currently, there are no effective treatments for infected banana plantations which can cause 100% yield loss. MustGrow’s highly-anticipated initial data is expected Q4-2020.
MustGrow has filed key patents and announced proof-of-concept data related to a biological non-selective bioherbicide (weed killer), a timely development, as market-leading herbicides face high-profile legal and regulatory challenges. A series of application rate tests achieved herbicidal control after only 72 hours – killing the plants from the root up. Additional program advancements are expected Q4-2020.
Canola / Clubroot Disease:
MustGrow has confirmed in soil and on plants an over 98% control of Clubroot spores in 24-hours. Clubroot is a rapidly-spreading disease pathogen destroying canola, one of Canada’s more profitable crops. Once a field is infested, there are no economical control measures currently available, with some field infections leading to 100% crop loss.
The World is Ready for Biopesticides
Widely-used synthetic chemicals continue to be banned or deregistered globally. The U.S. EPA promotes and encourages the use of safer pesticides, requiring much less data to register a biopesticide. The European Commission is seeking to halve the use of chemical pesticides by 2030. Leading agriculture companies have recently established venture capital programs to fund, partner or acquire early-stage technologies focused on biopesticide & bioherbicide crop protection. Research firm Markets and Markets sees the global biopesticide market size doubling to US$8.5 billion by 2025.
MustGrow is a publicly traded (CSE: MGRO) (OTC: MGROF) (FRA:0C0) agriculture biotech company focused on providing natural science-based biological solutions for high value crops, including fruits & vegetables. MustGrow has designed and owns a United States EPA-approved natural solution that uses the mustard seed’s natural defence mechanism to protect plants from pests and diseases. Over 110 independent tests have been completed, validating MustGrow’s safe and effective signature products. The product, in granule format, is EPA-approved across all key U.S. states and by Health Canada’s PMRA (Pest Management Regulatory Agency) as a biopesticide for high value crops such as in fruit & vegetables. MustGrow has now concentrated a liquid format, TerraMG, and with regulatory approval, could be applied through standard drip or spray equipment, improving functionality and performance features.
The Company has approximately 37 million basic common shares issued and outstanding. For further details please visit www.mustgrow.ca.
ON BEHALF OF THE BOARD
Director & CEO
Certain statements included in this press release constitute “forward-looking statements” which involve known and unknown risks, uncertainties and other factors that may affect the results, performance or achievements of MustGrow.
Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, “is expected”, “budget”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might”, “occur” or “be achieved”.
Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of MustGrow to differ materially from those discussed in such forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, MustGrow.
These risks are described in more detail in MustGrow’s Prospectus and other continuous disclosure documents filed by MustGrow with the applicable securities regulatory authorities and available at www.sedar.com. Readers are referred to such documents for more detailed information about MustGrow, which is subject to the qualifications, assumptions and notes set forth therein.
This release does not constitute an offer for sale of, nor a solicitation for offers to buy, any securities in the United States.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
© 2020 MustGrow Biologics Corp. All rights reserved.